Ribon Therapeutics, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Ribon Therapeutics, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2022.
Ribon Therapeutics at a glance
What does Ribon Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $25 million sold (2022).
Frequently asked questions about Ribon Therapeutics
Where is Ribon Therapeutics headquartered?
Ribon Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Ribon Therapeutics do?
Ribon Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Ribon Therapeutics founded?
The earliest incorporation on record for Ribon Therapeutics, Inc. is in 2015, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences